[1]
Grotenhermen F, Müller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 2012; 109(29-30): 495-501.
[2]
Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 2006; 105(1-2): 1-25.
[3]
Warf B. High points: An historical geography of cannabis. Geogr Rev 2014; 104(4): 414-38.
[4]
Brand EJ, Zhao Z. Cannabis in Chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids? Front Pharmacol 2017; 8: 108.
[5]
Perrot S. Cannabis: the analgesic and antiinflammatory medication of the future? Joint Bone Spine 2004; 71(1): 7-8.
[6]
Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 2010; 71(17-18): 2058-73.
[7]
Casajuana KC, López-Pelayo H, Balcells-Olivero MM, Colom J, Gual A. Psychoactive constituents of cannabis and their clinical implications: a systematic review. Adicciones 2018; 30(2): 140-51.
[8]
Gould J. The cannabis crop. Nature 2015; 525(7570): S2-3.
[9]
Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) 2006; 45(1): 50-2.
[10]
Shang VC, Kendall DA, Roberts REΔ. 9-Tetrahydrocannabinol reverses TNFα-induced increase in airway epithelial cell permeability through CB2 receptors. Biochem Pharmacol 2016; 120: 63-71.
[11]
Murray RM, Quigley H, Quattrone D, Englund A, Di Forti M. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry 2016; 15(3): 195-204.
[12]
Gul W, Gul SW, Chandra S, Lata H, Ibrahim EA, ElSohly MA. Detection and quantification of Cannabinoids in extracts of Cannabis sativa roots using LC-MS/MS. Planta Med 2018; 84(4): 267-71.
[13]
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011; 163(7): 1344-64.
[14]
Bergamaschi MM, Queiroz RHC, Zuardi AW, Crippa JA. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 2011; 6(4): 237-49.
[15]
Russo EB, Jiang HE, Li X, et al. Phytochemical and genetic analyses of ancient cannabis from Central Asia. J Exp Bot 2008; 59(15): 4171-82.
[16]
Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) 2005; 181(1): 170-8.
[17]
Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 2009; 34(3): 672-80.
[18]
Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 2006; 7(5): 607-15.
[19]
Agência Nacional de Vigilância Sanitária Resolução da Diretoria Colegiada - RDC n° 66 Brasil: ANVISA;( RDC Nº 66) 2016.
[20]
Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 2009; 1(7): 1333-49.
[21]
Turcotte C, Chouinard F, Lefebvre JS, Flamand N. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. J Leukoc Biol 2015; 97(6): 1049-70.
[22]
Ahmed AU. An overview of inflammation: mechanism and consequences. Front Biol 2011; 6(4): 274-81.
[23]
Ashley NT, Weil ZM, Nelson RJ. Inflammation: mechanisms, costs, and natural variation. Annu Rev Ecol Evol Syst 2012; 43: 385-406.
[24]
Vergnolle N. The inflammatory response. Drug Dev Res 2003; 59(4): 375-81.
[25]
Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell 2015; 160(5): 816-27.
[26]
Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007; 42: 3-27.
[27]
Fokunang CN, Fokunang ET, Frederick K, et al. Overview of non-steroidal anti-inflammatory drugs (NSAIDs) in resource limited countries. MOJ Toxicol 2018; 4(1): 5-13.
[28]
Ong CKS, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res 2007; 5(1): 19-34.
[29]
Flower R. Steroidal antiinflammatory drugs as inhibitors of phospholipase A2. Adv Prostaglandin Thromboxane Res 1978; 3: 105-12.
[30]
Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med 2005; 353(16): 1711-23.
[31]
Buckenhueskes HJ. Industrial quality control. In: Berger RG, Ed. Flavours and Fragrances: Chemistry, Bioprocessing and Sustainability. Berlin: Springer 2007; pp. 303-12.
[32]
Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci 2007; 9(4): 413-30.
[33]
Punyamurthula NS, Hingorani T, Adelli G, et al. Controlled release tablet formulation containing natural (9)-tetrahydrocannabinol. Drug Dev Ind Pharm 2016; 42(7): 1158-64.
[34]
Thomas BF, Pollard GT. Preparation and distribution of Cannabis and Cannabis-derived dosage formulations for investigational and therapeutic use in the United States. Front Pharmacol 2016; 7(285): 285.
[36]
Hornby AP, Hornby AP. Hayley’s Comet II CA2859934 2014.
[37]
Hornby AP. Hornby AP Hayley’s Comet CA2737447A1. 2011.
[38]
Tianrui C, Jingyue H. Anti-hepatitis medicine. CN105963356A 2016.
[39]
Zhang K, Liu J, Sun H. Hemp extract with antisensitive moisturizing effect and application thereof. CN105998195A 2016.
[40]
Tianrui C, Jingyue H. Application of a Cannabis extract in the preparation of a medicament for treating gouty arthritis. CN106074493A 2016.
[41]
Wallace HW. Method of relieving analgesia and Reducing inflamation using a Cannabinoid delivery. US6,949,582 2005.
[42]
Lansky EP. Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts. WO2010150245A1 2010.